Sign Up to like & get
recommendations!
0
Published in 2017 at "International journal of cardiology"
DOI: 10.1016/j.ijcard.2017.01.123
Abstract: OBJECTIVES Exenatide is a glucagon-like peptide-1 analogue that mitigates myocardial injury caused by ischemia-reperfusion injury via the survival signaling pathway. We hypothesized that exenatide would provide a protective effect in doxorubicin-induced cardiotoxicity. METHODS H9c2 cardiomyocytes…
read more here.
Keywords:
dox induced;
doxorubicin induced;
induced cardiotoxicity;
treatment ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "Journal of Veterinary Internal Medicine"
DOI: 10.1111/jvim.70069
Abstract: ABSTRACT Background Insulin‐treated diabetic cats frequently achieve transient remission. The glucagon‐like peptide‐1 receptor agonist, exenatide extended‐release (exenatide‐ER), preserves β cell function in people with type 2 diabetes mellitus (DM). Objectives Investigate the effect of exenatide‐ER…
read more here.
Keywords:
exenatide;
exenatide extended;
extended release;
remission ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "BMC Endocrine Disorders"
DOI: 10.1186/s12902-022-00932-9
Abstract: Background We investigated the changes in blood glucose fluctuation, gastric emptying, and vascular endothelial function by switching from an exenatide twice-daily formulation (BID) to a once-weekly formulation (QW) since the evaluation of postprandial glucose excursion…
read more here.
Keywords:
gastric emptying;
endothelial function;
vascular endothelial;
exenatide ... See more keywords